Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors (PNETs) are becoming increasingly common, with the majority of patients presenting with either lymph node involvement or metastatic disease, thus requiring systemic therapy. Targeted therapy is a type of medication that blocks the growth of cancer cells by interferin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiedmann, Marcus W., Mössner, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511053/
https://www.ncbi.nlm.nih.gov/pubmed/23226079
http://dx.doi.org/10.4137/CMO.S7350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511053/
https://www.ncbi.nlm.nih.gov/pubmed/23226079
http://dx.doi.org/10.4137/CMO.S7350

Ejemplares similares